Four Tips to Make Indoor, Winter Air Hepatitis C Friendly
Discover four tips that can help those with Hepatitis C avoid additional liver damage from the high percentage of toxins found in wintertime indoor air.
Continue reading »Discover four tips that can help those with Hepatitis C avoid additional liver damage from the high percentage of toxins found in wintertime indoor air.
Continue reading »A small study of Inovio Biomedical's Hepatitis C vaccine employing electric pulse technology yields encouraging safety data.
Continue reading »Hepatitis C identification and care trends published in the December 2009 issue of Hepatology indicate a national, public health dilemma deserving of congressional action.
Continue reading »Scientists from Rockefeller University uncover some insights into the Hepatitis C genome that suggests new avenues for weakening this insidious virus.
Continue reading »A recent study revealed that a therapeutic vaccine combined with a topical immune-enhancing agent initiated an immune response against the Hepatitis C virus.
Continue reading »Lichen planus, a recurring skin condition that often manifests with Hepatitis C infection, can cause intense itching and pain. Learn about the skin disease's characteristics and commonly affected regions - as well as six strategies that may help reduce your risk of lichen planus from returning.
Continue reading »Learn about a phase II trial, whereby Boceprevir was added to standard Hepatitis C therapy (pegylated interferon and ribavirin) and was twice as effective at eliminating the Hep C virus compared to standard therapy alone.
Continue reading »Find out about a Henry Ford retrospective study of liver transplant recipients, which discovered that extending antiviral treatment length significantly reduced the chances of Hepatitis C recurring.
Continue reading »For some individuals, living with chronic hepatitis can mean having a face full of blemishes. While many feel helpless over their skin's appearance, the physiological connection between hepatitis and acne suggests that those with liver disease do have some control over preventing skin breakouts.
Continue reading »In just three days of a phase I trial, Idenix's experimental, nucleotide-containing Hepatitis C drug (IDX184) demonstrates excellent safety and antiviral activity.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window